Yi-Chun Wang

发表

ABT-888 Confers Broad In vivo Activity in Combination with Temozolomide in Diverse Tumors

P. Ellis, X. Liu, V. Giranda, 2009, Clinical Cancer Research.

The RTK inhibitor, ABT-869 alone or in combination with various cytotoxic therapies demonstrate significant tumor growth inhibition in orthotopic hepatocellular carcinoma, renal cell carcinoma and prostate xenografts

S. Davidsen, J. O'Connor, Baole Wang, 2007 .

Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605

S. Davidsen, Eric F. Johnson, N. Soni, 2009, BMC Cancer.

Two‐chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5

D. Shaw, R. Sakthivel, K. Claffey, 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Correlation of tumor growth suppression and methionine aminopetidase-2 activity blockade using an orally active inhibitor

Qian Zhang, L. Tucker, Jieyi Wang, 2008, Proceedings of the National Academy of Sciences.

A highly potent and selective farnesyltransferase inhibitor ABT-100 in preclinical studies

V. Stoll, T. Holzman, S. Muchmore, 2005, Anti-cancer drugs.

Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities.

S. Badylak, F. Haviv, J. Henkin, 2005, Journal of Medicinal Chemistry.

Galangin ameliorates cisplatin‐induced nephrotoxicity by attenuating oxidative stress, inflammation and cell death in mice through inhibition of ERK and NF‐kappaB signaling

Ming-Shiun Tsai, Yu‐Ching Huang, Ting-Hui Lin, 2017, Toxicology and applied pharmacology.

Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor

K. Glaser, S. Davidsen, Eric F. Johnson, 2005, Molecular Cancer Therapeutics.

Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2.

Scott A. Erickson, J. Maris, Chang H. Park, 2003, Cancer research.

The XRCC 3 Thr 241 Met Polymorphism Influences Glioma RiskA Meta-analysis

Li Zhang, Yi-Chun Wang, Jun Jiang, 2013 .

The XRCC3 Thr241Met polymorphism influences glioma risk - a meta-analysis.

Li Zhang, Yi-Chun Wang, Jun Jiang, 2013, Asian Pacific journal of cancer prevention : APJCP.

Comparative effects of cellulose and soluble fibers (pectin, konjac glucomannan, inulin) on fecal water toxicity toward Caco-2 cells, fecal bacteria enzymes, bile acid, and short-chain fatty acids.

Yi-Chun Wang, Hsiao‐ling Chen, You Lin, 2010, Journal of agricultural and food chemistry.

Lack of association between COX-2 8473T>C polymorphism and breast cancer risk: a meta-analysis

Li Zhang, Yi-Chun Wang, Mingxia Zhang, 2014, Contemporary oncology.

Correlation of tumor growth suppression and methionine aminopetidase-2 activity blockade using an orally active inhibitor

Qian Zhang, L. Tucker, Jieyi Wang, 2008, Proceedings of the National Academy of Sciences.